16 October 2023
16 October 2023
A novel infrastructure for storing, consulting and analysing medical data will be presented at the Open Day of the Champalimaud Foundation (FC) Breast Unit, which is taking place today, October 16. It was created by the Unit's Digital Surgery Lab, a multidisciplinary team led by surgeon Pedro Gouveia, in partnership with the telecommunications company Altice and the Portuguese company BMD Software.
28 September 2023
A side-effect “is any effect of a drug, chemical, or other medicine that is in addition to its intended effect, especially an effect that is harmful or unpleasant”.
Malignant melanoma is a highly aggressive form of skin cancer that is on the rise. However, recent breakthrough research has introduced new targeted therapies and immunotherapies for melanoma treatment, transforming the approach to treating melanoma and offering hope to patients with limited alternatives.
21 September 2023
In the midst of a territory that has long been a hotspot for armed confrontation and humanitarian instability, the St John of Jerusalem Eye Hospital Group (SJEHG) has managed to provide top quality eye care, as well as ophthalmic training to local medical professionals.
“For its commitment to providing essential eye care in a region marked by conflict”, the Group has now been recognized with the one-million-euro 2023 António Champalimaud Vision Award, the Champalimaud Foundation announced in a statement.